Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Serotype and Commodity Contributions to Quinolone Resistance Trends Among FSIS NARMS Salmonella Isolates, 2013-2023.

Created on 08 Oct 2026

Authors

Christopher Morales

Published in

Foodborne pathogens and disease. Pages 15353141261497353. Oct 07, 2026. Epub Oct 07, 2026.

Abstract

Food-animal surveillance can identify antimicrobial-resistance patterns that may affect foodborne disease risk, but pooled summaries can obscure commodity and serotype drivers. This study analyzed public FSIS NARMS cecal and HACCP/slaughter-source Salmonella records accessed through FDA NARMS Now to examine quinolone-resistance trends by calendar period, commodity, and serotype. Records were filtered to Salmonella isolates with reported growth collected from 2013 to 2023. Calendar periods were defined descriptively as 2013-2016, 2017-2022, and 2023 to bracket major U.S. antimicrobial-stewardship milestones, including completion of GFI #213 implementation in 2017 and implementation of GFI #263 in 2023; these periods were treated as temporal landmarks rather than causal policy exposures. Outcomes were ciprofloxacin non-susceptibility, ciprofloxacin resistance only, and nalidixic acid resistance. Analyses included commodity-stratified percentages with Wilson 95% confidence intervals, serotype contribution summaries, and binomial models with standard errors clustered by year. The dataset included 42,232 Salmonella isolates; 41,608 were tested for ciprofloxacin and 41,606 for nalidixic acid. Overall, ciprofloxacin non-susceptibility increased from 1.96% in 2013-2016 to 17.84% in 2017-2022 and 25.71% in 2023. Nalidixic acid resistance increased from 1.36% to 17.02% and 24.01%, respectively. These increases were concentrated in chickens, where ciprofloxacin non-susceptibility rose from 1.7% to 28.7% and 42.4%. Salmonella Infantis accounted for 75.0% of all ciprofloxacin non-susceptible isolates, and Infantis plus Enteritidis accounted for 85.6%. After excluding both serotypes, adjusted period odds ratios were substantially attenuated. Findings indicate that quinolone-resistance trends in FSIS NARMS food-animal Salmonella data were strongly shaped by chicken-associated serotype composition, supporting serotype-aware surveillance.

PMID:
42844810
Bibliographic data and abstract were imported from PubMed on 08 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 12
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement